News

Study details the enormous cost of neurological diseases to the USA.

A new method to fight influenza A (H1N1) focuses on training our bodies immunity to the virus faster.

The new test offers rapid and sensitive detection of flu virus.

The test outperforms others on the market and takes just hours to complete.

numares will deploy its Magnetic Group Signaling® (MGS®) technology platform to accelerate research and development of a non-invasive MS diagnostic test.

Bristol-Myers Squibb enters collaboration to leverage Foundation Medicine’s molecular information platform to identify predictive biomarkers across multiple tumor types and immunotherapy agents.

Researchers at Case Western Reserve University School of Medicine have successfully grown stem cells from children with a devastating neurological disease to help explain how different genetic backgrounds can cause common symptoms.

Chemists at the University of Alabama at Birmingham have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.

Japanese researchers identify process to improve fluorescence detection of cancer stem cells, which are primarily responsible for brain tumor progression and recurrence after treatment

Similarities and differences among astrocytomas and oligodendrogliomas may suggest new treatment approaches.